Purchase Order 75A50120P00113
Award Date 9/30/20
Potential Completion Date 6/29/21
Potential Value $169K
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20024, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded Laboratory Corporation of America a $4.59 million firm fixed price purchase order to provide COVID-19 laboratory testing services from March 18, 2020 to August 14, 2020. The purpose of this ratification was to cover services already provided from March 18 to May 5, 2020 totaling $4.59 million. Laboratory Corporation of America, as the prime contractor, will perform the testing at its...
- The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded Laboratory Corporation of America a $12.99 million firm fixed-price purchase order to provide COVID-19 laboratory testing services from May 6, 2020 through July 31, 2020 under a ratification action. The purpose of the purchase order was to ratify laboratory testing performed for HHS under Contract BTS 1.0 from the initial period of need. As the prime contractor, Laboratory Corporation of...
- This is a $91,693,500.00 firm-fixed-price definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp), a leading global life sciences company, for COVID-19 laboratory testing services. The contract has an ultimate completion date of April 22, 2025. Labcorp, a for-profit organization headquartered in Burlington, North Carolina, is the prime contractor and does not have any set-aside designation. The contract is not...
- This $149,949.15 firm fixed price delivery order was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Laboratory Corporation of America for COVID-19 testing services for FDA employees and contractors. The contract has a period of performance through July 18, 2023 and no set-aside designation was used. As the largest commercial clinical laboratory network in the world, Laboratory Corporation of America will leverage its extensive experience and...
- The Department of Health and Human Services Food and Drug Administration awarded a $190,775 firm fixed price delivery order contract to Laboratory Corporation of America Holdings for COVID-19 testing for 2,500 ORA employees. As the parent company of Laboratory Corporation of America, the prime contractor awarded, Laboratory Corporation of America will provide coronavirus testing to support FDA inspectional activities. No set-aside designation was used for this contract awarded on September 15,...
- This federal contract award was issued by the U.S. Secret Service, a civilian agency, to Laboratory Corporation of America (Labcorp) for the delivery of COVID-19 test kits. The contract, valued at $172,500.00, has an ultimate completion date of August 9, 2021 and is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type. The contract was awarded on August 7, 2020 and does not have a set-aside designation, indicating Labcorp was competitively selected. Labcorp is a leading...
- This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Laboratory Corporation Of America Holdings, a global life sciences leader that provides laboratory diagnostic services. The contract is for HLA testing services, with a potential value of $587,926.66 and a completion date of March 31, 2023. The contract is not set-aside. Laboratory Corporation Of America Holdings has previously provided serology testing services to support COVID-19 response efforts...
- This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $20,069.53 to provide COVID-19 testing for FDA employees and contractors. The prime contractor is Laboratory Corporation of America of Burlington, North Carolina, a subsidiary of Laboratory Corporation of America Holdings. The firm fixed price order is for coronavirus disease 2019 testing services to support the FDA's mission during the ongoing pandemic. No set-aside designation...
- The U.S. Department of the Army Medical Command awarded a firm fixed price delivery order contract for $300,074.75 to Laboratory Corporation of America (LabCorp), a leading global life sciences company, for clinical reference laboratory testing services. This contract was not set aside and does not appear to be part of a larger contracting vehicle. LabCorp has been awarded numerous federal contracts to provide medical laboratory testing and analysis services in support of government healthcare...
- This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...